BioStem Technologies, Inc.
BSEM
$4.04
$0.123.07%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.47M | -45.60M | 72.53M | 254.81M | 18.41M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.47M | -45.60M | 72.53M | 254.81M | 18.41M |
| Cost of Revenue | 1.20M | 685.20K | 853.40K | 3.53M | 4.24M |
| Gross Profit | 9.27M | -46.28M | 71.67M | 251.28M | 14.17M |
| SG&A Expenses | 5.80M | -48.41M | 64.68M | 241.46M | 4.34M |
| Depreciation & Amortization | 57.60K | 60.70K | 54.00K | 62.50K | 54.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.02M | -45.71M | 67.28M | 246.33M | 9.12M |
| Operating Income | 1.45M | 112.80K | 5.25M | 8.48M | 9.29M |
| Income Before Tax | 1.47M | 178.00K | 5.28M | 8.42M | 9.15M |
| Income Tax Expenses | 707.70K | 742.30K | 797.40K | -7.10M | 2.33M |
| Earnings from Continuing Operations | 761.10K | -564.40K | 4.48M | 15.52M | 6.82M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 761.10K | -564.40K | 4.48M | 15.52M | 6.82M |
| EBIT | 1.45M | 112.80K | 5.25M | 8.48M | 9.29M |
| EBITDA | 1.51M | 173.50K | 5.30M | -- | 9.34M |
| EPS Basic | 0.05 | -0.03 | 0.27 | 0.94 | 0.42 |
| Normalized Basic EPS | 0.05 | 0.01 | 0.20 | -- | 0.35 |
| EPS Diluted | 0.03 | -0.03 | 0.17 | 0.63 | 0.32 |
| Normalized Diluted EPS | 0.04 | 0.01 | 0.13 | -- | 0.27 |
| Average Basic Shares Outstanding | 16.75M | 16.71M | 16.67M | 16.54M | 16.32M |
| Average Diluted Shares Outstanding | 23.24M | 16.71M | 26.26M | 24.48M | 21.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |